Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtronic Enters Market For Smartphone-enabled Glucose Monitoring Systems
Bidness Etc.
Tuesday, October 7, 2014 - 7:47am
tags:
Medtronic, diabetes, devices, blood glucose monitoring, Medtronic Guardian Mobile, smartphones
AbbVie's Humira Receives FDA Approval for JIA
Drug Discovery and Development
Tuesday, October 7, 2014 - 7:45am
tags:
AbbVie, Humira, FDA, juvenile idiopathic arthritis
FDA approves emergency use of Chimerix's Brincidofovir
Seeking Alpha
Tuesday, October 7, 2014 - 7:43am
tags:
FDA, Chimerix, Brincidofovir, ebola virus
Allergan Asks Judge to Block Ackman From Voting Stock at Meeting
Bloomberg
Tuesday, October 7, 2014 - 7:39am
tags:
Allergan, Valeant Pharmaceuticals, Bill Ackman, M&A
BrainStorm gets FDA fast-track status for ALS stem cell therapy
Yahoo/Reuters
Tuesday, October 7, 2014 - 7:38am
tags:
BrainStorm Cell Therapeutics, FDA, ALS, stem cells
Number of companies fighting Ebola grows, one wins fed OK
Marketwatch
Monday, October 6, 2014 - 9:28pm
tags:
ebola virus, Chimerix, Tekmira Pharmaceuticals, NewLink Genetics, NanoViricides, Crucell, GSK
Sanofi Notifies U.S. About Overseas Bribery Allegations
Bloomberg
Monday, October 6, 2014 - 9:22pm
tags:
Sanofi, bribery, Africa, Middle East
Is Teva knocking on Mylan's door? With inversion deal at risk, maybe
Fierce Pharma
Monday, October 6, 2014 - 6:45pm
tags:
Teva Pharmaceutical, Mylan Labs, tax inversions, M&A
Mylan Surges on Improved Q3 and Full-Year Earnings Outlook
Yahoo/Zacks.com
Monday, October 6, 2014 - 6:42pm
tags:
earnings, Mylan Labs
Will Biotech Beat This Earnings Season?
Barron's
Monday, October 6, 2014 - 6:05pm
tags:
earnings, Gilead Sciences, Celgene, Biogen Idec
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Monday, October 6, 2014 - 11:51am
tags:
Sanofi, Novo Nordisk, basal insulin, diabetes, Lantus, Levemir
What a Pain! FDA Fires Back At Critics of its Zohydro Policy
WSJ Pharmalot
Monday, October 6, 2014 - 11:48am
tags:
Zohydro ER, Zogenix, FDA
Why GSK Has Been Immune To Ebola Gains
Bidness Etc.
Monday, October 6, 2014 - 11:46am
tags:
GSK, ebola virus, NewLink Genetics, Tekmira Pharmaceuticals
Vivus announces journal publication of Qsymia study results in type 2 diabetes
Seeking Alpha
Monday, October 6, 2014 - 11:05am
tags:
Vivus, Qsymia, type 2 diabetes
Why Is Sanofi Betting on MannKind Corporation's Afrezza?
Motley Fool
Monday, October 6, 2014 - 10:57am
tags:
Sanofi, MannKind, diabetes, Afrezza
Tekmira: Too Much, Too Soon?
Barron's
Monday, October 6, 2014 - 10:55am
tags:
Tekmira Pharmaceuticals, TKM-EBOLA, ebola virus
Chimerix Wants Its Piece of the Ebola Pie
24/7 Wall St
Monday, October 6, 2014 - 10:54am
tags:
Chimerix, ebola virus, Brincidofovir
Fierce Biotech's Top Women in Biotech 2014
Fierce Biotech
Monday, October 6, 2014 - 9:48am
tags:
biotech
Teva Stops R&D In Other Therapeutic Areas, Including Oncology And Women's Health
NASDAQ.com
Monday, October 6, 2014 - 9:46am
tags:
Teva Pharmaceutical, R&D, oncology, Women's Health
Actavis buying Durata Therapeutics for $616.4
Yahoo/AP
Monday, October 6, 2014 - 9:18am
tags:
Actavis, Durata Therapeutics, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.